Literature DB >> 15389844

Bacterial proteomics and its role in antibacterial drug discovery.

Heike Brötz-Oesterhelt1, Julia Elisabeth Bandow, Harald Labischinski.   

Abstract

Gene-expression profiling technologies in general, and proteomic technologies in particular have proven extremely useful to study the physiological response of bacterial cells to various environmental stress conditions. Complex protein toolkits coordinated by sophisticated regulatory networks have evolved to accommodate bacterial survival under ever-present stress conditions such as varying temperatures, nutrient availability, or antibiotics produced by other microorganisms that compete for habitat. In the last decades, application of man-made antibacterial agents resulted in additional bacterial exposure to antibiotic stress. Whereas the targeted use of antibiotics has remarkably reduced human suffering from infectious diseases, the ever-increasing emergence of bacteria that are resistant to antibiotics has led to an urgent need for novel antibiotic strategies. The intent of this review is to present an overview of the major achievements of proteomic approaches to study adaptation networks that are crucial for bacterial survival with a special emphasis on the stress induced by antibiotic treatment. A further focus will be the review of the, so far few, published efforts to exploit the knowledge derived from bacterial proteomic studies directly for the antibacterial drug-discovery process. Copyright (c) 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15389844     DOI: 10.1002/mas.20030

Source DB:  PubMed          Journal:  Mass Spectrom Rev        ISSN: 0277-7037            Impact factor:   10.946


  14 in total

1.  Evaluating the suitability of essential genes as targets for antibiotic screening assays using proteomics.

Authors:  Ashley Chessher
Journal:  Protein Cell       Date:  2012-01       Impact factor: 14.870

Review 2.  Challenges of antibacterial discovery.

Authors:  Lynn L Silver
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 3.  Mass spectrometry-based proteomics and its application to studies of Porphyromonas gingivalis invasion and pathogenicity.

Authors:  Richard J Lamont; Marina Meila; Qiangwei Xia; Murray Hackett
Journal:  Infect Disord Drug Targets       Date:  2006-09

4.  Proteomic signature of fatty acid biosynthesis inhibition available for in vivo mechanism-of-action studies.

Authors:  Michaela Wenzel; Malay Patra; Dirk Albrecht; David Y-K Chen; K C Nicolaou; Nils Metzler-Nolte; Julia E Bandow
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

5.  Computational Study on the Dynamics of Mycobacterium Tuberculosis RNA Polymerase Assembly.

Authors:  Sneha Bheemireddy; Narayanaswamy Srinivasan
Journal:  Methods Mol Biol       Date:  2022

6.  Classification of antimicrobial mechanism of action using dynamic bacterial morphology imaging.

Authors:  Xudong Ouyang; Jelmer Hoeksma; Ronnie J M Lubbers; Tjalling K Siersma; Leendert W Hamoen; Jeroen den Hertog
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

7.  The changes of proteomes components of Helicobacter pylori in response to acid stress without urea.

Authors:  Chunhong Shao; Qunye Zhang; Wei Tang; Wei Qu; Yabin Zhou; Yundong Sun; Han Yu; Jihui Jia
Journal:  J Microbiol       Date:  2008-07-05       Impact factor: 3.422

Review 8.  Breaking the Spell: Combating Multidrug Resistant 'Superbugs'.

Authors:  Shahper N Khan; Asad U Khan
Journal:  Front Microbiol       Date:  2016-02-18       Impact factor: 5.640

9.  2-DE analysis indicates that Acinetobacter baumannii displays a robust and versatile metabolism.

Authors:  Nelson C Soares; Maria P Cabral; José R Parreira; Carmen Gayoso; Maria J Barba; Germán Bou
Journal:  Proteome Sci       Date:  2009-09-28       Impact factor: 2.480

Review 10.  Technologies for High-Throughput Identification of Antibiotic Mechanism of Action.

Authors:  Bernardo Ribeiro da Cunha; Paulo Zoio; Luís P Fonseca; Cecília R C Calado
Journal:  Antibiotics (Basel)       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.